Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease
Identifieur interne : 000842 ( Pmc/Curation ); précédent : 000841; suivant : 000843Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease
Auteurs : T. Celeste Napier [États-Unis] ; Jean-Christophe Corvol [France] ; Anthony A. Grace [États-Unis] ; Jamie D. Roitman [États-Unis] ; James Rowe [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; Antonio P. Strafella [Canada]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2014.
Abstract
Patients with Parkinson’s disease (PD) may experience impulse control disorders (ICDs) when on dopamine agonist therapy for their motor symptoms. In the last few years, there has been a rapid growth of interest for the recognition of these aberrant behaviors and their neurobiological correlates. Recent advances in neuroimaging are helping to identify the neuroanatomical networks responsible for these ICDs, and together with psychopharmacological assessments are providing new insights into the brain status of impulsive behavior. The genetic associations that may be unique to ICDs in PD are also being identified. Complementing human studies, electrophysiological and biochemical studies in animal models are providing insights into neuropathological mechanisms associated with these disorders. New animal models of ICDs in PD patients are being implemented that should provide critical means to identify efficacious therapies for PD-related motor deficits while avoiding ICD side effects. Here, we provide an overview of these recent advances, with a particular emphasis on the neurobiological correlates reported in animal models and patients along with their genetic underpinnings.
Url:
DOI: 10.1002/mds.26068
PubMed: 25476402
PubMed Central: 4318759
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000842
Links to Exploration step
PMC:4318759Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease</title>
<author><name sortKey="Napier, T Celeste" sort="Napier, T Celeste" uniqKey="Napier T" first="T. Celeste" last="Napier">T. Celeste Napier</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Corvol, Jean Christophe" sort="Corvol, Jean Christophe" uniqKey="Corvol J" first="Jean-Christophe" last="Corvol">Jean-Christophe Corvol</name>
<affiliation wicri:level="1"><nlm:aff id="A2">UPMC, APHP, ICM, INSERM CIC-1422 and UMRS 1027, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, APHP, ICM, INSERM CIC-1422 and UMRS 1027, Department of Neurology, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Departments of Neuroscience, Psychiatry and Psychology, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neuroscience, Psychiatry and Psychology, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Roitman, Jamie D" sort="Roitman, Jamie D" uniqKey="Roitman J" first="Jamie D." last="Roitman">Jamie D. Roitman</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Department of Psychology and Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago, IL USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Psychology and Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Rowe, James" sort="Rowe, James" uniqKey="Rowe J" first="James" last="Rowe">James Rowe</name>
<affiliation wicri:level="1"><nlm:aff id="A5">Department of Clinical Neurosciences; Behavioural and Clinical Neuroscience Institute; and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences; Behavioural and Clinical Neuroscience Institute; and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name>
<affiliation wicri:level="1"><nlm:aff id="A6">Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences; University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P." last="Strafella">Antonio P. Strafella</name>
<affiliation wicri:level="1"><nlm:aff id="A7">Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25476402</idno>
<idno type="pmc">4318759</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318759</idno>
<idno type="RBID">PMC:4318759</idno>
<idno type="doi">10.1002/mds.26068</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000842</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000842</idno>
<idno type="wicri:Area/Pmc/Curation">000842</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000842</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease</title>
<author><name sortKey="Napier, T Celeste" sort="Napier, T Celeste" uniqKey="Napier T" first="T. Celeste" last="Napier">T. Celeste Napier</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Corvol, Jean Christophe" sort="Corvol, Jean Christophe" uniqKey="Corvol J" first="Jean-Christophe" last="Corvol">Jean-Christophe Corvol</name>
<affiliation wicri:level="1"><nlm:aff id="A2">UPMC, APHP, ICM, INSERM CIC-1422 and UMRS 1027, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, APHP, ICM, INSERM CIC-1422 and UMRS 1027, Department of Neurology, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Departments of Neuroscience, Psychiatry and Psychology, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neuroscience, Psychiatry and Psychology, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Roitman, Jamie D" sort="Roitman, Jamie D" uniqKey="Roitman J" first="Jamie D." last="Roitman">Jamie D. Roitman</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Department of Psychology and Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago, IL USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Psychology and Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Rowe, James" sort="Rowe, James" uniqKey="Rowe J" first="James" last="Rowe">James Rowe</name>
<affiliation wicri:level="1"><nlm:aff id="A5">Department of Clinical Neurosciences; Behavioural and Clinical Neuroscience Institute; and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences; Behavioural and Clinical Neuroscience Institute; and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name>
<affiliation wicri:level="1"><nlm:aff id="A6">Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences; University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P." last="Strafella">Antonio P. Strafella</name>
<affiliation wicri:level="1"><nlm:aff id="A7">Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P2">Patients with Parkinson’s disease (PD) may experience impulse control disorders (ICDs) when on dopamine agonist therapy for their motor symptoms. In the last few years, there has been a rapid growth of interest for the recognition of these aberrant behaviors and their neurobiological correlates. Recent advances in neuroimaging are helping to identify the neuroanatomical networks responsible for these ICDs, and together with psychopharmacological assessments are providing new insights into the brain status of impulsive behavior. The genetic associations that may be unique to ICDs in PD are also being identified. Complementing human studies, electrophysiological and biochemical studies in animal models are providing insights into neuropathological mechanisms associated with these disorders. New animal models of ICDs in PD patients are being implemented that should provide critical means to identify efficacious therapies for PD-related motor deficits while avoiding ICD side effects. Here, we provide an overview of these recent advances, with a particular emphasis on the neurobiological correlates reported in animal models and patients along with their genetic underpinnings.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Mov. Disord.</journal-id>
<journal-title-group><journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">25476402</article-id>
<article-id pub-id-type="pmc">4318759</article-id>
<article-id pub-id-type="doi">10.1002/mds.26068</article-id>
<article-id pub-id-type="manuscript">NIHMS638089</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Napier</surname>
<given-names>T. Celeste</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Corvol</surname>
<given-names>Jean-Christophe</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Grace</surname>
<given-names>Anthony A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Roitman</surname>
<given-names>Jamie D.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rowe</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Voon</surname>
<given-names>Valerie</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Strafella</surname>
<given-names>Antonio P.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA</aff>
<aff id="A2"><label>2</label>
UPMC, APHP, ICM, INSERM CIC-1422 and UMRS 1027, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France</aff>
<aff id="A3"><label>3</label>
Departments of Neuroscience, Psychiatry and Psychology, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA</aff>
<aff id="A4"><label>4</label>
Department of Psychology and Laboratory of Integrative Neuroscience, University of Illinois at Chicago, Chicago, IL USA</aff>
<aff id="A5"><label>5</label>
Department of Clinical Neurosciences; Behavioural and Clinical Neuroscience Institute; and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK</aff>
<aff id="A6"><label>6</label>
Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK</aff>
<aff id="A7"><label>7</label>
Morton and Gloria Shulman Movement Disorder Unit - E.J. Safra Parkinson Disease Program, Toronto Western Hospital and Research Institute, UHN & Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada</aff>
<author-notes><corresp id="cor1"><bold>Corresponding Author:</bold>
1. T. Celeste Napier, Ph.D., Director, Center for Compulsive Behavior and Addiction, Professor, Departments of Pharmacology and Psychiatry, Rush University Medical Center, Suites 424 and 426, Cohn Research Building, 1735 W. Harrison Str., Chicago 60612, voice phone: 312 563-2428, Fax: 312 563-2403, <email>Celeste_Napier@Rush.edu</email>
</corresp>
<fn id="FN1" fn-type="equal"><label>*</label>
<p id="P1">These authors contributed equally to this report; names listed alphabetically.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>29</day>
<month>10</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub"><day>05</day>
<month>12</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub"><month>2</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>2</month>
<year>2016</year>
</pub-date>
<volume>30</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>149</lpage>
<pmc-comment>elocation-id from pubmed: 10.1002/mds.26068</pmc-comment>
<abstract><p id="P2">Patients with Parkinson’s disease (PD) may experience impulse control disorders (ICDs) when on dopamine agonist therapy for their motor symptoms. In the last few years, there has been a rapid growth of interest for the recognition of these aberrant behaviors and their neurobiological correlates. Recent advances in neuroimaging are helping to identify the neuroanatomical networks responsible for these ICDs, and together with psychopharmacological assessments are providing new insights into the brain status of impulsive behavior. The genetic associations that may be unique to ICDs in PD are also being identified. Complementing human studies, electrophysiological and biochemical studies in animal models are providing insights into neuropathological mechanisms associated with these disorders. New animal models of ICDs in PD patients are being implemented that should provide critical means to identify efficacious therapies for PD-related motor deficits while avoiding ICD side effects. Here, we provide an overview of these recent advances, with a particular emphasis on the neurobiological correlates reported in animal models and patients along with their genetic underpinnings.</p>
</abstract>
<kwd-group><kwd>Dopamine agonists</kwd>
<kwd>pramipexole</kwd>
<kwd>L-DOPA</kwd>
<kwd>6-OHDA</kwd>
<kwd>imaging</kwd>
<kwd>PET</kwd>
<kwd>fMRI</kwd>
<kwd>basal ganglia</kwd>
<kwd>prefrontal cortex</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000842 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000842 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:4318759 |texte= Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:25476402" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |